Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NVAX

NOVAVAX INC

CIK 0001000694 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$9.40
↑ 0.05 (0.53%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$1.55B
P/E Ratio
-17.60
EPS
2.72
Dividend Yield
Not covered
52W Position
55%
Beta
2.01

Valuation multiples

Fwd P/E
2.59
PEG
1.32
P/B
-10.68
P/S
2.59
EV/Revenue
2.70
ROE
60.7%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 55%
$6.20$11.97

Latest Financials

2025-12-31 FY
Revenue
$1.12B
Net Income
$440.30M
Total Assets
$1.18B
Free Cash Flow
-$250.19M

Recent news